80
Participants
Start Date
August 9, 2019
Primary Completion Date
January 28, 2021
Study Completion Date
January 28, 2021
Losmapimod oral tablet
Losmapimod will be administered with food when possible.
Placebo oral tablet
Placebo will be administered with food when possible
University of Rochester Medical Center, Rochester
Kennedy Krieger Institute, Baltimore
Virginia Commonwealth University, Richmond
University of Florida, Gainesville
Ohio State University, Columbus
Hospital UiP La Fe, Valencia
Washington University School of Medicine, St Louis
University of Kansas Medical Center, Kansas City
University of Utah, Salt Lake City
University of California Los Angeles (UCLA), Los Angeles
University of California Irvine, Irvine
University of Washinton Medical Center, Seattle
University of Massachusetts Memorial Medical Center, Worcester
Ottawa Hospital Research Institute, Ottawa
Montreal Neurological Institute and Hospital, Montreal
CHU de NICE- CHU pasteur2, Nice
Hospital de la Sta Creu i St Pau, Barcelona
Lead Sponsor
Fulcrum Therapeutics
INDUSTRY